Resistance to Trastuzumab in HER2-Positive Mucinous Invasive Ductal Breast Carcinoma.

Resistance to Trastuzumab in HER2-Positive Mucinous Invasive Ductal Breast Carcinoma.
Clin Breast Cancer. 2012 Dec 28;
Authors: Baretta Z, Guindalini RS, Khramtsova G, Olopade OI
PMID: 23276464 [PubMed - as supplied by publisher]

Source: Clinical Breast Cancer - December 28, 2012 Category: Cancer & Oncology Authors: Baretta Z, Guindalini RS, Khramtsova G, Olopade OI Tags: Clin Breast Cancer Source Type: research